JP2020518651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518651A5 JP2020518651A5 JP2019561277A JP2019561277A JP2020518651A5 JP 2020518651 A5 JP2020518651 A5 JP 2020518651A5 JP 2019561277 A JP2019561277 A JP 2019561277A JP 2019561277 A JP2019561277 A JP 2019561277A JP 2020518651 A5 JP2020518651 A5 JP 2020518651A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- abu
- fine particles
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762502913P | 2017-05-08 | 2017-05-08 | |
| US62/502,913 | 2017-05-08 | ||
| PCT/US2018/031663 WO2018208829A1 (en) | 2017-05-08 | 2018-05-08 | Biodegradable microparticles for sustained delivery of anti-angiogenic peptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020518651A JP2020518651A (ja) | 2020-06-25 |
| JP2020518651A5 true JP2020518651A5 (https=) | 2021-07-26 |
Family
ID=64104968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019561277A Withdrawn JP2020518651A (ja) | 2017-05-08 | 2018-05-08 | 抗血管新生ペプチドの持続送達のための生分解性微粒子 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200179285A1 (https=) |
| EP (1) | EP3621597A4 (https=) |
| JP (1) | JP2020518651A (https=) |
| KR (1) | KR20200003859A (https=) |
| CN (1) | CN111315364A (https=) |
| AU (1) | AU2018266690A1 (https=) |
| CA (1) | CA3063140A1 (https=) |
| WO (1) | WO2018208829A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018187530A1 (en) | 2017-04-06 | 2018-10-11 | Sustain Holdings, Llc | Collagen peptide-based medicament compositions and devices and methods of production and use thereof |
| EP3661536A4 (en) | 2017-08-03 | 2021-07-21 | Asclepix Therapeutics, Inc. | PROCESS FOR IDENTIFICATION AND MANUFACTURING OF PHARMACEUTICAL INGREDIENTS FOR ACTIVATING A TIE2 RECEPTOR |
| CN113710264A (zh) * | 2019-03-26 | 2021-11-26 | 阿斯克雷佩西治疗公司 | 用于治疗眼部疾病的组合物和方法 |
| AU2020262096B2 (en) | 2019-04-22 | 2026-04-23 | Sustain Holdings, Llc | Collagen peptide-based medicament compositions and devices and methods of production and use thereof |
| IT202100023357A1 (it) | 2021-09-09 | 2023-03-09 | Cheirontech S R L | Peptidi con attività anti-angiogenica |
| CN117126233A (zh) * | 2022-05-20 | 2023-11-28 | 杭州禾泰健宇生物科技有限公司 | 一种类肽化合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9717694B2 (en) * | 2009-05-15 | 2017-08-01 | The Johns Hopkins University | Peptide/particle delivery systems |
| US10314917B2 (en) * | 2013-03-15 | 2019-06-11 | The Brigham And Women's Hospital, Inc. | Targeted polymeric inflammation-resolving nanoparticles |
| JP6470740B2 (ja) * | 2013-06-07 | 2019-02-13 | ザ ジョンズ ホプキンス ユニバーシティ | 血管新生およびリンパ管新生依存性疾患の処置のための生体模倣ペプチドおよび生分解性送達プラットフォーム |
| MX2019003895A (es) * | 2016-10-04 | 2019-10-07 | Asclepix Therapeutics Inc | Compuestos y metodos para activar la señalizacion tie2. |
-
2018
- 2018-05-08 US US16/612,124 patent/US20200179285A1/en not_active Abandoned
- 2018-05-08 KR KR1020197035367A patent/KR20200003859A/ko not_active Ceased
- 2018-05-08 CA CA3063140A patent/CA3063140A1/en not_active Abandoned
- 2018-05-08 JP JP2019561277A patent/JP2020518651A/ja not_active Withdrawn
- 2018-05-08 WO PCT/US2018/031663 patent/WO2018208829A1/en not_active Ceased
- 2018-05-08 EP EP18797771.5A patent/EP3621597A4/en not_active Withdrawn
- 2018-05-08 AU AU2018266690A patent/AU2018266690A1/en not_active Abandoned
- 2018-05-08 CN CN201880039876.3A patent/CN111315364A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518651A5 (https=) | ||
| Ward et al. | Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres | |
| JP6700348B2 (ja) | 持続型薬物送達インプラント | |
| JP2018500394A5 (https=) | ||
| JP2008528446A5 (https=) | ||
| US10231937B2 (en) | Process for encapsulating soluble biologics, therapeutics, and imaging agents | |
| ES2782111T3 (es) | Micropartículas cargadas con ciclosporina de liberación sostenida | |
| JP2019535651A5 (https=) | ||
| US9044436B2 (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| JP2020518651A (ja) | 抗血管新生ペプチドの持続送達のための生分解性微粒子 | |
| CA2891365A1 (en) | Composition for immediate and extended release | |
| CN1638734A (zh) | 微粒结膜下给药的药物释放系统 | |
| US20150306170A1 (en) | Composition for immediate and extended release | |
| EP3810087A1 (en) | Bioresponsive hydrogel matrixes and methods of use | |
| JP2025118607A5 (https=) | ||
| CN118384281A (zh) | 聚乙二醇化尿酸酶的制剂和剂量 | |
| RU2409348C2 (ru) | Лекарственные составы с контролируемым высвобождением, основанные на блок-сополимерах | |
| JP2024531314A5 (https=) | ||
| RU2476235C2 (ru) | Композиции на основе биосовместимых микрочастиц альгиновой кислоты, предназначенные для регулируемого высвобождения активных ингредиентов при внутривенном введении | |
| KR101732609B1 (ko) | 생리활성물질의 순차적 방출제어를 위한 고분자 혼합 제제 | |
| JP2022527276A5 (https=) | ||
| TWI660740B (zh) | 水膠組合物及包含其之藥物傳輸系統 | |
| CN107970204B (zh) | 水凝胶组合物及包含其的药物递送系统 | |
| CN120267619A (zh) | 一种奥氮平长效缓释微球制剂及其制备方法与应用 | |
| CN104906587B (zh) | 一种膦甲酸钠眼玻璃体腔内缓释药物 |